Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
319,727,097
-
Share change
-
-8,120,753
-
Total reported value
-
$13,922,259,966
-
Put/Call ratio
-
46%
-
Price per share
-
$43.53
-
Number of holders
-
823
-
Value change
-
-$354,564,281
-
Number of buys
-
398
-
Number of sells
-
423
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q2 2022
As of 30 Jun 2022,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
823 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
319,727,097 shares.
The largest 10 holders included
Dodge & Cox, Fisher Asset Management, LLC, Capital International Investors, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, ACADIAN ASSET MANAGEMENT LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, RENAISSANCE TECHNOLOGIES LLC, JTC Employer Solutions Trustee Ltd, and STATE STREET CORP.
This page lists
823
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.